Combined risk of myocardial infarction by tertiles of factor XIc and factor XIIc
FXIc/FXIIc . | Patients . | Control subjects . | OR (95% CI)* . | OR (95% CI)† . |
---|---|---|---|---|
FXIc less than 100% | ||||
FXIIc more than 109% | 5 | 26 | 1‡ | 1‡ |
FXIIc 91%-109% | 44 | 72 | 3.3 (1.2-9.3) | 4.5 (0.5-38.9) |
FXIIc less than 91% | 82 | 110 | 4.1 (1.5-11.1) | 7.4 (0.9-61.4) |
FXIc 100%-116% | ||||
FXIIc more than 109% | 28 | 76 | 1.9 (0.7-5.4) | 2.5 (0.3-22.5) |
FXIIc 91%-109% | 84 | 85 | 5.3 (1.9-14.6) | 15.0 (1.8-122.0) |
FXIIc less than 91% | 114 | 62 | 9.9 (3.6-27.2) | 17.6 (2.1-145.0) |
FXIc more than 116% | ||||
FXIIc more than 109% | 80 | 111 | 3.7 (1.4-10.1) | 7.4 (0.9-60.5) |
FXIIc 91%-109% | 69 | 59 | 6.1 (2.2-17.0) | 5.6 (0.6-47.9) |
FXIIc less than 91% | 54 | 45 | 6.4 (2.2-18.0) | 11.6 (1.4-98.5) |
FXIc/FXIIc . | Patients . | Control subjects . | OR (95% CI)* . | OR (95% CI)† . |
---|---|---|---|---|
FXIc less than 100% | ||||
FXIIc more than 109% | 5 | 26 | 1‡ | 1‡ |
FXIIc 91%-109% | 44 | 72 | 3.3 (1.2-9.3) | 4.5 (0.5-38.9) |
FXIIc less than 91% | 82 | 110 | 4.1 (1.5-11.1) | 7.4 (0.9-61.4) |
FXIc 100%-116% | ||||
FXIIc more than 109% | 28 | 76 | 1.9 (0.7-5.4) | 2.5 (0.3-22.5) |
FXIIc 91%-109% | 84 | 85 | 5.3 (1.9-14.6) | 15.0 (1.8-122.0) |
FXIIc less than 91% | 114 | 62 | 9.9 (3.6-27.2) | 17.6 (2.1-145.0) |
FXIc more than 116% | ||||
FXIIc more than 109% | 80 | 111 | 3.7 (1.4-10.1) | 7.4 (0.9-60.5) |
FXIIc 91%-109% | 69 | 59 | 6.1 (2.2-17.0) | 5.6 (0.6-47.9) |
FXIIc less than 91% | 54 | 45 | 6.4 (2.2-18.0) | 11.6 (1.4-98.5) |